PLA2G7 and coronary artery disorder: Wu et al.14 showed that ACS patients had a significantly higher level of serum Lp-PLA2 (233 ± 54 μg/l) than patients without coronary artery disease (208 ± 52 μg/l), with a statistically significant difference (p < 0.01), and the Lp-PLA2 concentration was correlated with the change in LDL-C level.